An EU-funded chemist has won a share of the Nobel Prize in Chemistry for a technique that enables researchers to peer into the nanoworld of individual molecules.
Professor Stefan W. Hell, who has received EU funding multiple times, won the prize alongside US researchers Professor William E. Moerner and Dr Eric Betzig. The trio are credited with creating microscopes that can see at a greater resolution than half the wavelength of light.
That’s significant because Ernst Abbe, a famous microscopist in the 1800s, had used mathematics to show that scientists would never be able to view organisms with a microscope which were smaller than that.
‘So much physics happened in the twentieth century that it was impossible that there was no phenomenon that wouldn’t allow you to overcome the physical diffraction barrier that was coined in 1873 or so,’ Prof. Hell said in an audio interview posted on the Nobel Prize website. ‘I felt that there had to be something.’
In 1994 as a post-doctoral researcher at the University of Turku, in Finland, he published a theoretical article outlining how he could use fluorescence techniques to build a kind of flashlight which would generate an image of far greater resolution than previously achieved.
‘It was impossible that there was no phenomenon that wouldn’t allow you to overcome the physical diffraction barrier.’
Professor Stefan W. Hell
He received funding from Marie Skłodowska-Curie Actions (MSCA) to work on so-called fluorescence microscopy and then was invited to the Max Planck Institute for Biophysical Chemistry in Germany. Here he managed to develop one of these microscopes, and in the year 2000 he imaged an E.coli bacterium at a never-before-seen resolution.
Having benefitted from the MSCA grant himself, Professor Hell later coordinated three MSCA individual fellowships. He and his fellow researchers at the Max Planck Institute for Biophysical Chemistry in Göttingen also participated in collaborative projects funded by the EU, including the FLUODIAMON project which looked at using fluorescence microscopy to detect cancer. This year, three Nobel Prizes – for Physiology/Medicine, Physics and Chemistry – have all had links to the EU’s MSCA programme.
European Commissioner Androulla Vassiliou, responsible for the MCSA scheme and European Commissioner for Research, Innovation and Science Máire Geoghegan-Quinn said in a joint statement: ‘Outstanding researchers like Stefan W. Hell are an excellent example of what European research mobility can achieve.’
Prof. Moerner and Dr Betzig, developed a separate method called single-molecule microscopy.
These discoveries mean that researchers can now track proteins involved in diseases like Parkinson’s and Alzheimer’s, and follow individual proteins in fertilized eggs as these divide into embryos.
Decoding how the human egg matures and how this process can go wrong could lead to ways of preventing genetic errors leading to infertility, birth defects or pregnancy loss.
New weapons are needed to fight drug-resistant bacteria, one of the biggest threats to global health. By working on new antibiotics or finding ways to revive existing ones in our medical arsenal, scientists aim to avoid a return to a world where even everyday infections may mean death.
When it comes to planes cruising through the air, many of us are used to the idea of them flying on autopilot with little or no input from a human pilot as they travel from one destination to another. Landing a plane under autopilot, known as autoland, is a different matter. While some systems already exist, efforts are underway to improve them to enable safer landings.
Researchers across Europe have started to speed up the evolutionary process of yeast to develop new or better flavours for wine and beer. The objective is for beer and wine producers to better accommodate changing consumer tastes and trends, such as anti-GMO sentiments and demand for low-alcohol products.
Infrared sensors could make taxi, take-off, cruise and landing safer.
New research also reveals that a fertilised egg repairs itself before developing further.
Beyond antibiotic overuse, there may be other causes behind this global threat, says microbiologist.